TCL Archive Outside NIH, Applied Research Underfunded; Strong Federal Role Needed, Chabner Says May 12, 1995
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista March 12, 1999
